资讯
内科
心血管
肿瘤
内分泌
普通内科
消化
呼吸
神经科
传染科
精神心理
肾内科
风湿免疫
血液科
老年医学
外科
头颈外科
胃肠外科
血管外科
肝胆胰外
骨科
普通外科
胸心外科
神经外科
泌尿外科
烧伤科
整形美容
麻醉疼痛
专科科室
罕见病
康复医学
药械
儿科
耳鼻咽喉
口腔科
眼科
政策人文
营养全科
预防公卫
妇产科
中医科
急重症
皮肤性病
影像放射
转化医学
检验病理
护理
热点
临床研究
研究设计
人工智能
智慧医疗
论文基金
医学科普
药物经济
医生集团
职业安全
患者招募
医学科研
公司产业
医学英语
MedSci动态
指南
按科室浏览
肿瘤科
心血管
传染科
妇产科
神经科
儿科
呼吸
内分泌科
血液科
消化
更多科室
工具
临床工具
临床指南
医学计算与公式
ICD-10/ICD-11疾病编码
医讯达
直播
话题
公开课
精品课
科研工具
期刊数据库查询
期刊智能选择
全球基金查询
文献查询
SCI写作宝典
生物医药大词典
其他工具
下载App使用方便更快捷
Medsci 梅斯搜索
公开课
精品课
服务
科研数智化
直播,公开课与精品课
科研加速器
研究者发起的临床研究(IIS)支持
真实世界研究解决方案
药物经济学
医保准入事务
研究方案设计
数据库建立与管理
药物警戒(PV)
真实世界研究执行
数据统计分析
数字化学术传播解决方案
多渠道营销(MCM)
产品医学策略
学术传播(APO)
其它
积分商城
FAQS
#Oncology#
195篇内容 | 3426人围观
关注话题
话题活跃用户
#
插入话题
插入图片
评论
最新
最热
GetTopicDetailResponse(id=e8aa13359b1, topicName=Oncology, introduction=Oncology, content=null, image=null, comments=195, allHits=3426, url=https://h5.medsci.cn/topic?id=13359, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=8392, tagList=[TagDto(tagId=8392, tagName=Oncology)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1674374, encodeId=a2b716e43741d, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, objectTitle=Oncology:治疗延迟是否会对进展期胃癌患者预后造成不良影响, objectType=article, longId=55483, objectId=5f71554837e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f71554837e, replyNumber=0, likeNumber=67, createdTime=2015-11-01, rootId=0, userName=circumcision, userId=cb7226973259, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f71554837e, moduleTitle=Oncology:治疗延迟是否会对进展期胃癌患者预后造成不良影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f71554837e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674371, encodeId=209716e437119, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, objectTitle=JAMA Oncology:癌症晚期,化疗真的正确么?, objectType=article, longId=54062, objectId=fc2a5406283, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc2a5406283, replyNumber=0, likeNumber=69, createdTime=2015-10-21, rootId=0, userName=circumcision, userId=cb7226973259, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc2a5406283, moduleTitle=JAMA Oncology:癌症晚期,化疗真的正确么?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc2a5406283)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674358, encodeId=a8fc16e435831, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, objectTitle=Lancet Oncology:靶向药物使霍奇金淋巴瘤患者生存期翻倍, objectType=article, longId=48443, objectId=ff284844386, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff284844386, replyNumber=0, likeNumber=47, createdTime=2015-04-18, rootId=0, userName=circumcision, userId=cb7226973259, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff284844386, moduleTitle=Lancet Oncology:靶向药物使霍奇金淋巴瘤患者生存期翻倍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff284844386)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674347, encodeId=4fd816e4347b6, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, objectTitle=The lancet oncology:白血病治疗的曙光!blinatumomab试验效果乐观, objectType=article, longId=45203, objectId=ca4545203c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca4545203c0, replyNumber=0, likeNumber=62, createdTime=2015-07-31, rootId=0, userName=circumcision, userId=cb7226973259, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca4545203c0, moduleTitle=The lancet oncology:白血病治疗的曙光!blinatumomab试验效果乐观, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca4545203c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674379, encodeId=099716e43791e, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, objectTitle=Psychooncology:年轻癌症患者过的“性福”吗?, objectType=article, longId=58161, objectId=94c6581618a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94c6581618a, replyNumber=0, likeNumber=61, createdTime=2016-08-10, rootId=0, userName=circumcision, userId=cb7226973259, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94c6581618a, moduleTitle=Psychooncology:年轻癌症患者过的“性福”吗?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94c6581618a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674364, encodeId=77ea16e4364b2, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, objectTitle=JAMA Oncology:减肥有理!肥胖增加非裔美国人患前列腺癌风险, objectType=article, longId=49523, objectId=d492495236b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d492495236b, replyNumber=0, likeNumber=74, createdTime=2015-07-15, rootId=0, userName=circumcision, userId=cb7226973259, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d492495236b, moduleTitle=JAMA Oncology:减肥有理!肥胖增加非裔美国人患前列腺癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d492495236b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674349, encodeId=662916e43491a, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, objectTitle=Lancet Oncology:老年患早期乳腺癌术后建议辅助放疗, objectType=article, longId=46348, objectId=cda846348e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cda846348e8, replyNumber=0, likeNumber=63, createdTime=2015-05-07, rootId=0, userName=circumcision, userId=cb7226973259, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cda846348e8, moduleTitle=Lancet Oncology:老年患早期乳腺癌术后建议辅助放疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cda846348e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674351, encodeId=220816e4351b1, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, objectTitle=The Lancet Oncology:前列腺癌放疗:推荐标准分次疗法, objectType=article, longId=46601, objectId=c68d4660105, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c68d4660105, replyNumber=0, likeNumber=53, createdTime=2015-02-03, rootId=0, userName=circumcision, userId=cb7226973259, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c68d4660105, moduleTitle=The Lancet Oncology:前列腺癌放疗:推荐标准分次疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c68d4660105)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674363, encodeId=237716e436389, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, objectTitle=日本科学家因数据问题撤销Oncology(《肿瘤学》)论文, objectType=article, longId=49516, objectId=bb294951691, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb294951691, replyNumber=0, likeNumber=86, createdTime=2015-06-17, rootId=0, userName=circumcision, userId=cb7226973259, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb294951691, moduleTitle=日本科学家因数据问题撤销Oncology(《肿瘤学》)论文, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb294951691)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674350, encodeId=706316e4350b5, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, objectTitle=The Lancet Oncology:贝伐单抗有望用于治疗晚期宫颈癌, objectType=article, longId=46416, objectId=13de46416c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13de46416c3, replyNumber=0, likeNumber=66, createdTime=2015-04-24, rootId=0, userName=circumcision, userId=cb7226973259, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13de46416c3, moduleTitle=The Lancet Oncology:贝伐单抗有望用于治疗晚期宫颈癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13de46416c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674356, encodeId=2c6616e435625, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, objectTitle=Nature Reviews Clinical Oncology:安德森算法提高晚期卵巢癌的手术成功率, objectType=article, longId=47633, objectId=bf2b4e633e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf2b4e633e0, replyNumber=0, likeNumber=65, createdTime=2015-09-06, rootId=0, userName=circumcision, userId=cb7226973259, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf2b4e633e0, moduleTitle=Nature Reviews Clinical Oncology:安德森算法提高晚期卵巢癌的手术成功率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf2b4e633e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674372, encodeId=b93316e437207, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, objectTitle=JAMA Oncology:短疗程大剂量的放疗对早期乳腺癌患者的效果更好, objectType=article, longId=54720, objectId=915e54e20ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=915e54e20ae, replyNumber=0, likeNumber=70, createdTime=2016-04-23, rootId=0, userName=circumcision, userId=cb7226973259, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=915e54e20ae, moduleTitle=JAMA Oncology:短疗程大剂量的放疗对早期乳腺癌患者的效果更好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=915e54e20ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674367, encodeId=142116e436745, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, objectTitle=JAMA Oncology:他汀类药物有助于接受雄激素剥夺疗法的前列腺癌患者延缓疾病进展, objectType=article, longId=50492, objectId=8af75049242, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8af75049242, replyNumber=0, likeNumber=73, createdTime=2015-12-16, rootId=0, userName=circumcision, userId=cb7226973259, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8af75049242, moduleTitle=JAMA Oncology:他汀类药物有助于接受雄激素剥夺疗法的前列腺癌患者延缓疾病进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8af75049242)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674340, encodeId=0d4c16e43406d, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, objectTitle=Lancet Oncology:IBIS-II试验利塞膦酸钠可提高阿那曲唑骨质流失风险效益比, objectType=article, longId=42479, objectId=192c424e930, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=192c424e930, replyNumber=0, likeNumber=72, createdTime=2014-12-21, rootId=0, userName=circumcision, userId=cb7226973259, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=192c424e930, moduleTitle=Lancet Oncology:IBIS-II试验利塞膦酸钠可提高阿那曲唑骨质流失风险效益比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=192c424e930)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674353, encodeId=d9a716e4353f2, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, objectTitle=Lancet Oncology:高风险膀胱癌是否给予铂类辅助化疗?, objectType=article, longId=47448, objectId=2f164e448c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f164e448c8, replyNumber=0, likeNumber=55, createdTime=2015-06-15, rootId=0, userName=circumcision, userId=cb7226973259, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f164e448c8, moduleTitle=Lancet Oncology:高风险膀胱癌是否给予铂类辅助化疗?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f164e448c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674365, encodeId=984a16e436508, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, objectTitle=Lancet Oncology:对抗CTLA-4药物治疗后进展的黑色素瘤疗效对比,Nivolumab V.S 化疗, objectType=article, longId=49613, objectId=47e349613d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47e349613d4, replyNumber=0, likeNumber=53, createdTime=2015-07-18, rootId=0, userName=circumcision, userId=cb7226973259, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47e349613d4, moduleTitle=Lancet Oncology:对抗CTLA-4药物治疗后进展的黑色素瘤疗效对比,Nivolumab V.S 化疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47e349613d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674341, encodeId=572d16e434116, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, objectTitle=Lancet Oncology:联合奥沙利铂的辅助治疗可改善III期结肠癌患者存活率, objectType=article, longId=42601, objectId=ca28426010b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca28426010b, replyNumber=0, likeNumber=85, createdTime=2015-03-12, rootId=0, userName=circumcision, userId=cb7226973259, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca28426010b, moduleTitle=Lancet Oncology:联合奥沙利铂的辅助治疗可改善III期结肠癌患者存活率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca28426010b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674362, encodeId=d73c16e43620c, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, objectTitle=JAMA Oncology:NRAS和BRAF突变与高危型原发黑色素瘤生存期的关系, objectType=article, longId=49384, objectId=e11b4938401, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e11b4938401, replyNumber=0, likeNumber=90, createdTime=2015-04-18, rootId=0, userName=circumcision, userId=cb7226973259, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e11b4938401, moduleTitle=JAMA Oncology:NRAS和BRAF突变与高危型原发黑色素瘤生存期的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e11b4938401)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674339, encodeId=594416e433954, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, objectTitle=Lancet Oncology:Ramucirumab+紫杉醇治疗进展期胃癌疗效显著(RAINBOW Ⅲ期试验), objectType=article, longId=41720, objectId=873f41e2051, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=873f41e2051, replyNumber=0, likeNumber=58, createdTime=2014-11-24, rootId=0, userName=circumcision, userId=cb7226973259, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=873f41e2051, moduleTitle=Lancet Oncology:Ramucirumab+紫杉醇治疗进展期胃癌疗效显著(RAINBOW Ⅲ期试验), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=873f41e2051)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674338, encodeId=4ec116e4338b1, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, objectTitle=The Lancet Oncology:前哨淋巴阳性的胸腺癌患者腋下放射治疗或手术治疗, objectType=article, longId=41416, objectId=1653414166c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1653414166c, replyNumber=0, likeNumber=80, createdTime=2014-11-09, rootId=0, userName=circumcision, userId=cb7226973259, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1653414166c, moduleTitle=The Lancet Oncology:前哨淋巴阳性的胸腺癌患者腋下放射治疗或手术治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1653414166c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯话题小助手
关注
已关注
Oncology
2020-05-29
circumcision
(审核中...)
关注
已关注
前往app查看评论内容
#Oncology#
Oncology:治疗延迟是否会对进展期胃癌患者预后造成不良影响
67
0
2015-11-01
回复
circumcision
(审核中...)
关注
已关注
前往app查看评论内容
#Oncology#
JAMA Oncology:癌症晚期,化疗真的正确么?
69
0
2015-10-21
回复
circumcision
(审核中...)
关注
已关注
前往app查看评论内容
#Oncology#
Lancet Oncology:靶向药物使霍奇金淋巴瘤患者生存期翻倍
47
0
2015-04-18
回复
circumcision
(审核中...)
关注
已关注
前往app查看评论内容
#Oncology#
The lancet oncology:白血病治疗的曙光!blinatumomab试验效果乐观
62
0
2015-07-31
回复
circumcision
(审核中...)
关注
已关注
前往app查看评论内容
#Oncology#
Psychooncology:年轻癌症患者过的“性福”吗?
61
0
2016-08-10
回复
circumcision
(审核中...)
关注
已关注
前往app查看评论内容
#Oncology#
JAMA Oncology:减肥有理!肥胖增加非裔美国人患前列腺癌风险
74
0
2015-07-15
回复
circumcision
(审核中...)
关注
已关注
前往app查看评论内容
#Oncology#
Lancet Oncology:老年患早期乳腺癌术后建议辅助放疗
63
0
2015-05-07
回复
circumcision
(审核中...)
关注
已关注
前往app查看评论内容
#Oncology#
The Lancet Oncology:前列腺癌放疗:推荐标准分次疗法
53
0
2015-02-03
回复
circumcision
(审核中...)
关注
已关注
前往app查看评论内容
#Oncology#
日本科学家因数据问题撤销Oncology(《肿瘤学》)论文
86
0
2015-06-17
回复
circumcision
(审核中...)
关注
已关注
前往app查看评论内容
#Oncology#
The Lancet Oncology:贝伐单抗有望用于治疗晚期宫颈癌
66
0
2015-04-24
回复
circumcision
(审核中...)
关注
已关注
前往app查看评论内容
#Oncology#
Nature Reviews Clinical Oncology:安德森算法提高晚期卵巢癌的手术成功率
65
0
2015-09-06
回复
circumcision
(审核中...)
关注
已关注
前往app查看评论内容
#Oncology#
JAMA Oncology:短疗程大剂量的放疗对早期乳腺癌患者的效果更好
70
0
2016-04-23
回复
circumcision
(审核中...)
关注
已关注
前往app查看评论内容
#Oncology#
JAMA Oncology:他汀类药物有助于接受雄激素剥夺疗法的前列腺癌患者延缓疾病进展
73
0
2015-12-16
回复
circumcision
(审核中...)
关注
已关注
前往app查看评论内容
#Oncology#
Lancet Oncology:IBIS-II试验利塞膦酸钠可提高阿那曲唑骨质流失风险效益比
72
0
2014-12-21
回复
circumcision
(审核中...)
关注
已关注
前往app查看评论内容
#Oncology#
Lancet Oncology:高风险膀胱癌是否给予铂类辅助化疗?
55
0
2015-06-15
回复
circumcision
(审核中...)
关注
已关注
前往app查看评论内容
#Oncology#
Lancet Oncology:对抗CTLA-4药物治疗后进展的黑色素瘤疗效对比,Nivolumab V.S 化疗
53
0
2015-07-18
回复
circumcision
(审核中...)
关注
已关注
前往app查看评论内容
#Oncology#
Lancet Oncology:联合奥沙利铂的辅助治疗可改善III期结肠癌患者存活率
85
0
2015-03-12
回复
circumcision
(审核中...)
关注
已关注
前往app查看评论内容
#Oncology#
JAMA Oncology:NRAS和BRAF突变与高危型原发黑色素瘤生存期的关系
90
0
2015-04-18
回复
circumcision
(审核中...)
关注
已关注
前往app查看评论内容
#Oncology#
Lancet Oncology:Ramucirumab+紫杉醇治疗进展期胃癌疗效显著(RAINBOW Ⅲ期试验)
58
0
2014-11-24
回复
circumcision
(审核中...)
关注
已关注
前往app查看评论内容
#Oncology#
The Lancet Oncology:前哨淋巴阳性的胸腺癌患者腋下放射治疗或手术治疗
80
0
2014-11-09
回复
共195条
首页
上一页
下一页
尾页
页码:
8
/10页
20条/页
扫描二维码下载梅斯医学APP
科室
订阅+
更多科室
工具
服务